|
|
Article: Pain Therapeutics Announces Fourth Quarter and Year End 2004 Financial Results; Company Expects Phase III Results for Three Drug Candidates in 2005.
- Article from:
- PR Newswire
- Article date:
- January 26, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Pain Therapeutics, Inc. , a biopharmaceutical company, today reported financial results for the fourth quarter and year ended December 31, 2004.
The net loss for the quarter ended December 31, 2004 was $9.3 million, or $0.22 per share, compared to a net loss of $6.7 million, or $0.19 per share for the fourth quarter of 2003. The net loss for the year ended December 31, 2004 was $37.8 million, or $1.01 per share, compared to a net loss of $21.6 million, or $0.73 per share, for the same period of 2003.
At December 31, 2004 Pain Therapeutics' cash, cash equivalents and marketable securities were $99.4 million.
"We ended 2004 in great shape," said ...